Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Matthew M. Behymer"'
Autor:
Vik S Bebarta, Xu Shi, Shunning Zheng, Tara B Hendry-Hofer, Carter C Severance, Matthew M Behymer, Gerry R Boss, Sari Mahon, Matthew Brenner, Gregory T Knipp, Vincent Jo Davisson, Randall T Peterson, Calum A MacRae, Jared Rutter, Robert E Gerszten, Anjali K Nath
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology, vol 191, iss 1
Cyanide—a fast-acting poison—is easy to obtain given its widespread use in manufacturing industries. It is a high-threat chemical agent that poses a risk of occupational exposure in addition to being a terrorist agent. FDA-approved cyanide antido
Autor:
Matthew M. Behymer, Huaping Mo, Naoaki Fujii, Vallabh Suresh, Adriano Chan, Jangweon Lee, Anjali K. Nath, Kusumika Saha, Sari B. Mahon, Matthew Brenner, Calum A. MacRae, Randall Peterson, Gerry R. Boss, Gregory T. Knipp, Vincent Jo Davisson
Publikováno v:
Chemical research in toxicology, vol 35, iss 11
The development of rapidly acting cyanide countermeasures using intramuscular injection (IM) represents an unmet medical need to mitigate toxicant exposures in mass casualty settings. Previous work established that cisplatin and other platinum(II) or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84d80cd996b472fc32cd1fae2b0a49b3
https://escholarship.org/uc/item/5gf3017c
https://escholarship.org/uc/item/5gf3017c
Autor:
Anthony L. Sinn, Sandro Matosevic, Matthew M. Behymer, Karen E. Pollok, Gregory T. Knipp, Jiao Wang, Bennett D. Elzey, Randy R. Brutkiewicz, Sandra Toregrosa-Allen, Victor Bernal-Crespo, Kathryn S. Nevel, Nadia A. Lanman, Sagar M. Utturkar, Michael C. Veronesi, Yeonhee Yun
Publikováno v:
Proc Natl Acad Sci U S A
Tumor antigen heterogeneity, a severely immunosuppressive tumor microenvironment (TME) and lymphopenia resulting in inadequate immune intratumoral trafficking, have rendered glioblastoma (GBM) highly resistant to therapy. To address these obstacles,
Autor:
Jiao Wang, Sandra E. Torregrosa-Allen, Karen E. Pollok, Sagar M. Utturkar, Michael C. Veronesi, Matthew M. Behymer, Gregory T. Knipp, Anthony L. Sinn, Randy R. Brutkiewicz, Victor Bernal-Crespo, Yeonhee Yun, Sandro Matosevic, Nadia A. Lanman, Bennett D. Elzey, Kathryn S. Nevel
Tumor antigen heterogeneity, a severely immunosuppressive tumor microenvironment (TME) and lymphopenia resulting in inadequate immune intratumoral trafficking have rendered glioblastoma (GBM) highly resistant to therapy. As a result, GBM immunotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86eb180c1a7459bcff2e67e56ecd6511
https://doi.org/10.1101/2020.10.07.330043
https://doi.org/10.1101/2020.10.07.330043